Albert Bourla, Pfizer CEO (Laurent Gillieron/Keystone via AP Images)

On heels of record-break­ing Q2, Pfiz­er CEO Al­bert Bourla out­lines plans to ‘go very big’ on BD

Pfiz­er CEO Al­bert Bourla un­corked some record-break­ing Q2 num­bers on Thurs­day, in­clud­ing the com­pa­ny’s high­est-ever quar­ter­ly sales thanks to Comir­naty and Paxlovid, all while rais­ing the full-year guid­ance. What’s he go­ing to do with that cash?

“Go very big” on new deals, he said on the com­pa­ny’s Q2 call with in­vestors.

“We’re leav­ing very few stones un­turned when we look at op­por­tu­ni­ties,” chief busi­ness in­no­va­tion of­fi­cer Aamir Ma­lik added. “We’re go­ing to be very open to deal struc­tures, and we’ve said be­fore we’re al­so go­ing to be ag­nos­tic to size.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.